GRIFFETH INC. – Trademark Portfolio

Entity Type: 03

GRIFFETH INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include TRUGENTA, GFX INJECTION, and HEALTH RENUUL. The owner is based in VERO BEACH, FL.

5785 35TH STREET

VERO BEACH, FL 32966

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GRIFFETH INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does GRIFFETH INC. have?

GRIFFETH INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 1 abandoned.

What trademark classes does GRIFFETH INC. file in?

GRIFFETH INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are GRIFFETH INC.'s most well-known trademarks?

GRIFFETH INC.'s registered trademark portfolio includes well-known marks such as TRUGENTA, GFX INJECTION, and HEALTH RENUUL. These are among 3 currently registered trademarks in the portfolio.

What is GRIFFETH INC.'s trademark registration success rate?

GRIFFETH INC. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.